In murine models, CTLA-4 blockade has been demonstrated to enhance T cell responses to cancer vaccines and tumor infiltration along with intratumoral Treg depletion, resulting in tumor control and clearance (18, 26). The gene discussed is CTLA4; the disease is cancer.